Erros diagnósticos da síndrome da obesidade- -hipoventilação no Departamento de Emergência: uma série de casos
Barra lateral de artigos
Conteúdo do artigo principal
Resumo
Objetivo: Relatar casos de pacientes com diagnóstico posterior de síndrome da obesidade-hipoventilação e, retrospectivamente, as situações dos equívocos diagnósticos relacionados ao quadro nos ambientes de pronto-atendimento. Métodos: Estudo observacional, descritivo, exploratório e retrospectivo em prontuários de pacientes que procuraram Serviços de Emergência públicos e privados. Resultados: Foram avaliados 11 diagnósticos de síndrome da obesidade-hipoventilação, após atendimento de emergência. Pacientes apresentavam índice de massa corporal médio de 46.2 kg/m². Em 90.9% dos casos, não houve diagnóstico de síndrome da obesidade-hipoventilação no pronto-atendimento. Os principais motivos de procura do pronto atendimento foram infecções respiratórias e descompensação cardíaca. Todos os pacientes apresentavam sintomas de apneia obstrutiva do sono, e 90,9% tiveram diagnóstico equivocado de doença pulmonar obstrutiva crônica. Houve um óbito, e documentou-se tempo de internação prolongado. Conclusão: Destaca-se a compreensão limitada da síndrome da obesidade-hipoventilação por parte das unidades de urgência, o que resulta em dificuldades de obterem diagnósticos precisos e, consequentemente, o tratamento adequado.
Detalhes do artigo
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Referências
1. Obesity: preventing and managing the global epidemic. Report
of a WHO consultation. World Health Organ Tech Rep Ser.
2000;894:i-xii, 1-253.
2. Brasil. Ministério da Saúde. Obesidade. Biblioteca Virtual em
Saúde. 2009 [citado 2025 Jan 28]. Disponível em: https://bvsms.
saude.gov.br/obesidade-18/
3. Kivimäki M, Strandberg T, Pentti J, Nyberg ST, Frank P, Jokela
M, et al. Body-mass index and risk of obesity-related complex
multimorbidity: an observational multicohort study. Lancet
Diabetes Endocrinol. 2022;10(4):253-63.
4. Brasil. Ministério da Saúde. Vigitel Brasil 2023 - Vigilância de
Fatores de Risco e Proteção para Doenças Crônicas por Inquérito
Telefônico. Brasília, DF: Ministério da Saúde; 2023 [citado
2025 Jan 28] Disponível em: https://www.gov.br/saude/pt-br/
centrais-de-conteudo/publicacoes/svsa/vigitel/vigitel-brasil-
2023-vigilancia-de-fatores-de-risco-e-protecao-para-doencascronicas-
por-inquerito-telefonico/view
5. Di Giacinto I, Guarnera M, Esposito C, Falcetta S, Cortese G,
Pascarella G, et al. Emergencies in obese patients: a narrative
review. J Anesth Analg Crit Care. 2021;1(1):13.
6. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM.
Increased prevalence of sleep-disordered breathing in adults. Am
J Epidemiol. 2013;177(9):1006-14.
7. Jehan S, Zizi F, Pandi-Perumal SR, Wall S, Auguste E, Myers
AK, Jean-Louis G, et al. Obstructive sleep apnea and obesity:
implications for public health. Sleep Med Disord. 2017;1(4):00019.
8. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell
MJ, et al. Estimation of the global prevalence and burden of
obstructive sleep apnoea: a literature-based analysis. Lancet
Respir Med. 2019;7(8):687-98.
9. Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive
sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study.
Sleep Med. 2010;11(5):441-6.
10. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP.
Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47-112.
Erratum in: Physiol Rev.2010 Apr;90(2):797-8.
11. Lv R, Liu X, Zhang Y, Dong N, Wang X, He Y, et al. Pathophysiological
mechanisms and therapeutic approaches in obstructive sleep
apnea syndrome. Sig Transduct Target Ther. 2023;8(1):218. 12. Chau EHL, Mokhlesi B, Lam D, Wong J, Chung F. Obesity
hypoventilation syndrome. Anesthesiology. 117(1):18.
13. Mokhlesi B. Obesity hypoventilation syndrome: a state-ofthe-
art review. Respir Care. 2010;55(10):1347-62; discussion
1363-5.
14. Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans AT.
Obesity hypoventilation syndrome: prevalence and predictors
in patients with obstructive sleep apnea. Sleep Breath.
2007;11(2):117-24.
15. Athayde RAB, Oliveira Filho JRB, Lorenzi Filho G, Genta PR.
Obesity hypoventilation syndrome: a current review. J Bras
Pneumol. 2018;44(6):510-8.
16. Mokhlesi B, Masa JF, Brozek JL, Gurubhagavatula I, Murphy
PB, Piper AJ, et al. Evaluation and Management of Obesity
Hypoventilation Syndrome. An Official American Thoracic
Society Clinical Practice Guideline. Am J Respir Crit Care Med.
2019;200(3):e6-e24. Erratum in: Am J Respir Crit Care Med.
2019;200(10):1326.
17. Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky
WS, Gaudio JC, et al. Obesity-associated hypoventilation in
hospitalized patients: prevalence, effects, and outcome. Am J Med.
2004;116(1):1-7.
18. Owens RL. A big problem in the ICU. Initiation of CPAP/bilevel
PAP therapy. J Clin Sleep Med. 2014 Oct 15;10(10):1161-2.
19. Manthous CA, Mokhlesi B. Avoiding management errors in
patients with obesity hypoventilation syndrome. Ann Am Thorac
Soc. 2016;13(1):109-14.
20. Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of
health-care resources in obesity-hypoventilation syndrome.
Chest. 2001;120(2):377-83.
21. Piper AJ, Grunstein RR. Obesity hypoventilation syndrome:
mechanisms and management. Am J Respir Crit Care Med.
2011;183(3):292-8.
22. Baglyas S, Valkó L, Donka D, Fodor G, Hansági E, Méhész I, et al.
Prevalence of suspected obesity hypoventilation syndrome in
Hungarian Intensive Care Units during the COVID-19 pandemic.
Clin Respir J. 2023;17(8):771-9.
23. Basoglu OK, Tasbakan MS. Comparison of clinical characteristics
in patients with obesity hypoventilation syndrome and obese
obstructive sleep apnea syndrome: a case-control study. Clin
Respir J. 2014;8(2):167-74. 24. Gates KL, Howell HA, Nair A, Vohwinkel CU, Welch LC, Beitel GJ,
et al. Hypercapnia impairs lung neutrophil function and increases
mortality in murine pseudomonas pneumonia. Am J Respir Cell
Mol Biol. 2013;49(5):821-8.
25. Marik PE, Desai H. Characteristics of patients with the “malignant
obesity hypoventilation syndrome” admitted to an ICU. J Intensive
Care Med. 2013;28(2):124-30.
26. Masa JF, Pépin JL, Borel JC, Mokhlesi B, Murphy PB, Sánchez-
Quiroga MÁ. Obesity hypoventilation syndrome. Eur Respir Rev.
2019;28(151):180097.
27. Piper A. Obesity Hypoventilation Syndrome: Weighing in on
Therapy Options. Chest. 2016;149(3):856-68.
28. Howard ME, Piper AJ, Stevens B, Holland AE, Yee BJ, Dabscheck
E, et al. A randomised controlled trial of CPAP versus non-invasive
ventilation for initial treatment of obesity hypoventilation
syndrome. Thorax. 2017;72(5):437-44.
29. Zheng Y, Yee BJ, Wong K, Grunstein RR, Piper AJ. A comparison
of two obesity-related hypoventilation disorders: Impact on sleep,
quality of life and neurocognitive outcomes and the effects of
positive airway pressure therapy. Sleep Adv. 2024;5(1):zpae016.
30. Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized
trial comparing CPAP vs bilevel PAP spontaneous mode in the
treatment of hypoventilation disorder in patients with obesity and
obstructive airway disease. J Clin Sleep Med. 2022;18(1):99-107.
31. Ojeda Castillejo E, de Lucas Ramos P, López Martin S, Resano
Barrios P, Rodríguez Rodríguez P, Morán Caicedo L, et al.
Noninvasive mechanical ventilation in patients with obesity
hypoventilation syndrome. Long-term outcome and prognostic
factors. Arch Bronconeumol. 2015;51(2):61-8.
32. Masa JF, Corral J, Alonso ML, Ordax E, Troncoso MF, Gonzalez
M, et al.; Spanish Sleep Network. Efficacy of Different Treatment
Alternatives for Obesity Hypoventilation Syndrome. Pickwick
Study. Am J Respir Crit Care Med. 2015;192(1):86-95.
33. Park MH, Lee MJ, Kim JS, Park SH, Lee JH, Kim AJ. Veno-venous
extracorporeal membrane oxygenation rescue for pulmonary
hypertension and hypoxemic respiratory failure to obesity
hypoventilation syndrome: a case report. Ann Palliat Med.
2022;11(10):3341-45.
34. Borel JC, Borel AL, Piper AJ. NERO: a pilot study but important step
towards comprehensive management